Evidence map›Paper›PMID 15667650›Full record

ArticleBMC gastroenterology2005

Steroid-refractory ulcerative colitis treated with corticosteroids, metronidazole and vancomycin: a case report.

Jonathan Miner, M Monem Gillan, Philip Alex, Michael Centola

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC gastroenterology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jonathan MinerUniversity of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. Jminer@ouhsc.edu
M Monem Gillan
Philip Alex
Michael Centola
Oklahoma Medical Research Foundation · USUniversity of Oklahoma Health Sciences Center · US

Funding

VACCINE-TARGETED IDENTIFICATION OF FITNESS DETERMINANTS IN THE HIV-1 ENVELOPEP20RR016478 · NCRR · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI LEWIS, SHARON A · 2001 to 2011
$35.8M
THE EFFECTS OF ERK PATHWAY INHIBITION ON DNA METHYLATION IN SLEP20RR015577 · NCRR · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI CENTOLA, MICHAEL B · 2000 to 2009
$21.5M
NCRR NIH HHS 1 P20 RR15577NCRR NIH HHS 1 P20 RR16478NCRR NIH HHS P20 RR015577NCRR NIH HHS P20 RR016478
6 · The paper itself

Abstract

backgroundIncreasing evidence elucidating the pathogenic mechanisms of ulcerative colitis (UC) has accumulated and the disease is widely assumed to be the consequence of genetic susceptibility and an abnormal immune response to commensal bacteria. However evidence regarding an infectious etiology in UC remains elusive. CASE PRESENTATION: We report a provocative case of UC with profound rheumatologic involvement directly preceded by Clostridium difficile infection and accompanying fever, vomiting, bloody diarrhea, and arthritis. Colonic biopsy revealed a histopathology suggestive of UC. Antibiotic treatment eliminated detectable levels of enteric pathogens but did not abate symptoms. Resolution of symptoms was procurable with oral prednisone, but tapering of corticosteroids was only achievable in combination therapy with vancomycin and metronidazole.

conclusionsAn infectious pathogen may have both precipitated and exacerbated autoimmune disease attributes in UC, symptoms of which could be resolved only with a combination of corticosteroids, vancomycin and metronidazole. This may warrant the need for more perceptive scrutiny of C. difficile and the like in patients with UC.

Indexed as

Clostridioides difficileClostridium InfectionsAdultAnti-Bacterial AgentsAnti-Infective AgentsAnti-Inflammatory AgentsColitis, UlcerativeDose-Response Relationship, DrugDrug Administration ScheduleDrug ResistanceDrug Therapy, CombinationHumansMaleMetronidazolePrednisoneSteroidsAnti-Bacterial AgentsAnti-Infective AgentsAnti-Inflammatory AgentsMetronidazolePrednisoneSteroidsVancomycin

Identifiers

PMID15667650
PMCPMC548304
OpenAlexW1560708924

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.